Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_assertion type Assertion NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_head.
- NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_assertion description "[Increased RGS17 expression in some prostate and lung cancers has been demonstrated to support cancer progression, while reduced expression of RGS17 can lead to development of chemotherapeutic resistance in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_provenance.
- NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_assertion evidence source_evidence_literature NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_provenance.
- NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_assertion SIO_000772 23734683 NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_provenance.
- NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_assertion wasDerivedFrom befree-20150227 NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_provenance.
- NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_assertion wasGeneratedBy ECO_0000203 NP883822.RAmsKJk2ca41PA9Zx7yykg6BiGUYOrV6Q-4l1vBSuW46I130_provenance.